CN Patent

CN112679438A — 制备司美替尼的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2021-04-20 · 5y expired

What this patent protects

本发明涉及一种制备MEK1/2抑制剂司美替尼的方法，本发明的合成路线经三步反应合成得到司美替尼，其合成方法的后处理均无需柱层析分离，反应产物直接析出干燥即可。利用本发明所述的合成制备方法，其能够快速、有效地制备获得司美替尼。

USPTO Abstract

本发明涉及一种制备MEK1/2抑制剂司美替尼的方法，本发明的合成路线经三步反应合成得到司美替尼，其合成方法的后处理均无需柱层析分离，反应产物直接析出干燥即可。利用本发明所述的合成制备方法，其能够快速、有效地制备获得司美替尼。

Drugs covered by this patent

Patent Metadata

Patent number
CN112679438A
Jurisdiction
CN
Classification
—
Expires
2021-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.